Loading…
Terumo Neuro signed an agreement to acquire Arsenal Medical, a clinical-stage biomaterials company developing NeoCast, an investigational liquid embolic technology for treating chronic subdural hematoma. The acquisition expands Terumo Neuro's neurovascular portfolio.